Overview Financials News + Filings Key Docs Charts Ownership Insiders |
PEOPLES FINANCIAL CORP (PFBX)
|
Add to portfolio |
|
|
Price: |
$17.54
| | Metrics |
OS: |
4.68
|
M
| |
19
|
% ROE
|
Market cap: |
$82
|
M
| |
-204
|
% ROIC
|
|
|
| |
|
|
|
|
| | | |
| | | | | |
TTM Valuation | | | |
|
|
| |
|
|
|
|
| |
|
|
EPS |
$2.68
| |
6.5
|
x P/E
|
BVPS
|
$13.79
| |
1.27
|
x P/B
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 28.4 | 25.9 | 25.0 | 24.2 | 23.5 | 24.0 | 24.0 | 22.4 |
Revenue growth | 9.7% | 3.8% | 3.1% | 3.2% | -2.4% | 0.1% | 7.2% | 110.6% |
Cost of goods sold | 13.1 | 12.5 | 12.2 | 12.9 | 12.9 | 13.1 | 13.4 | 14.1 |
Gross profit | 15.3 | 13.4 | 12.7 | 11.3 | 10.6 | 11.0 | 10.6 | 8.3 |
Gross margin | 54.0% | 51.7% | 51.0% | 46.8% | 45.1% | 45.6% | 44.2% | 37.1% |
Selling, general and administrative | 4.3 | 4.3 | 4.3 | 4.4 | 4.5 | 4.3 | 4.3 | 4.2 |
General and administrative | 1.4 | 1.4 | 1.2 | 1.4 | 1.4 | 1.3 | 1.3 | 1.4 |
EBITA | -40.9 | -31.6 | -40.9 | -40.2 | -38.9 | -35.3 | -37.4 | -43.7 |
EBITA margin | -143.8% | -121.9% | -163.6% | -165.9% | -165.8% | -146.9% | -155.7% | -195.1% |
Amortization of intangibles | 0.0 | | | | | | | |
EBIT | -40.9 | -31.6 | -40.9 | -40.2 | -38.9 | -35.3 | -37.4 | -43.7 |
EBIT margin | -143.8% | -121.9% | -163.6% | -165.9% | -165.8% | -146.9% | -155.7% | -195.1% |
Pre-tax income | 6.5 | 9.0 | -2.6 | 1.7 | 0.6 | 1.7 | 0.2 | -4.6 |
Income taxes | -2.4 | 0.1 | 0.0 | 0.0 | 0.0 | -1.1 | 0.1 | 0.0 |
Tax rate | | 0.7% | 0.0% | 0.0% | | | 31.8% | 0.0% |
Net income | 8.9 | 8.9 | -2.6 | 1.7 | 0.6 | 2.8 | 0.2 | -4.6 |
Net margin | 31.4% | 34.4% | -10.2% | 6.9% | 2.7% | 11.5% | 0.7% | -20.5% |
|
Diluted EPS | $1.91 | $1.84 | ($0.52) | $0.34 | $0.13 | $0.54 | $0.03 | ($0.90) |
Shares outstanding (diluted) | 4.7 | 4.8 | 4.9 | 4.9 | 5.0 | 5.1 | 5.1 | 5.1 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|